Navigating the Canadian copyright landscape presents a tricky challenge. In terms of the law, dimethyltryptamine (copyright) remains strictly prohibited across the country . There are no sanctioned sources accessible for acquisition . However, interestingly , the decriminalized status of psilocybin, and the expanding acceptance of copyright therapy